JP2005538150A5 - - Google Patents

Download PDF

Info

Publication number
JP2005538150A5
JP2005538150A5 JP2004531341A JP2004531341A JP2005538150A5 JP 2005538150 A5 JP2005538150 A5 JP 2005538150A5 JP 2004531341 A JP2004531341 A JP 2004531341A JP 2004531341 A JP2004531341 A JP 2004531341A JP 2005538150 A5 JP2005538150 A5 JP 2005538150A5
Authority
JP
Japan
Prior art keywords
activity
estrogen
dose
phase
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004531341A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005538150A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2003/001325 external-priority patent/WO2004019954A1/en
Publication of JP2005538150A publication Critical patent/JP2005538150A/ja
Publication of JP2005538150A5 publication Critical patent/JP2005538150A5/ja
Pending legal-status Critical Current

Links

JP2004531341A 2002-08-28 2003-08-28 エストロゲン補充療法 Pending JP2005538150A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40633102P 2002-08-28 2002-08-28
PCT/CA2003/001325 WO2004019954A1 (en) 2002-08-28 2003-08-28 Estrogen replacement regimen

Publications (2)

Publication Number Publication Date
JP2005538150A JP2005538150A (ja) 2005-12-15
JP2005538150A5 true JP2005538150A5 (cg-RX-API-DMAC7.html) 2006-10-12

Family

ID=31978284

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004531341A Pending JP2005538150A (ja) 2002-08-28 2003-08-28 エストロゲン補充療法

Country Status (25)

Country Link
US (1) US8946198B2 (cg-RX-API-DMAC7.html)
EP (1) EP1539184B1 (cg-RX-API-DMAC7.html)
JP (1) JP2005538150A (cg-RX-API-DMAC7.html)
KR (1) KR20050059092A (cg-RX-API-DMAC7.html)
CN (1) CN1678324A (cg-RX-API-DMAC7.html)
AT (1) ATE345804T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003264203A1 (cg-RX-API-DMAC7.html)
BR (1) BR0313921A (cg-RX-API-DMAC7.html)
CA (1) CA2495330A1 (cg-RX-API-DMAC7.html)
CY (1) CY1106019T1 (cg-RX-API-DMAC7.html)
DE (1) DE60309895T2 (cg-RX-API-DMAC7.html)
DK (1) DK1539184T3 (cg-RX-API-DMAC7.html)
ES (1) ES2277139T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20050291A2 (cg-RX-API-DMAC7.html)
IL (1) IL166585A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA05002294A (cg-RX-API-DMAC7.html)
NO (1) NO20051545L (cg-RX-API-DMAC7.html)
NZ (1) NZ538342A (cg-RX-API-DMAC7.html)
PL (1) PL374762A1 (cg-RX-API-DMAC7.html)
PT (1) PT1539184E (cg-RX-API-DMAC7.html)
RS (1) RS20050184A (cg-RX-API-DMAC7.html)
RU (1) RU2340345C2 (cg-RX-API-DMAC7.html)
UA (1) UA82851C2 (cg-RX-API-DMAC7.html)
WO (1) WO2004019954A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200501274B (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
DE102009007771B4 (de) 2009-02-05 2012-02-16 Bayer Schering Pharma Aktiengesellschaft Bukkales Applikationssystem, 17α-Estradiol enthaltend
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP2782584B1 (en) 2011-11-23 2021-06-09 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
MX2016011801A (es) * 2014-03-12 2017-07-14 Warner Chilcott Co Llc Crema de estradiol de dosis baja.
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
LT3310345T (lt) 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
MA44206B1 (fr) 2015-06-18 2021-04-30 Estetra Sprl Comprimé orodispersible comprenant estetrol
EP3701944B1 (en) 2015-06-18 2021-12-08 Estetra SRL Orodispersible dosage unit containing an estetrol component
CU24523B1 (es) 2015-06-18 2021-06-08 Estetra Sprl Unidad de dosificación orodispersable que contiene un componente estetrol
JP2018522854A (ja) 2015-06-22 2018-08-16 リポカイン インコーポレーテッド 17−ヒドロキシプロゲステロンエステル含有経口組成物及び関連方法
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
EP3781171B1 (en) 2018-04-19 2022-02-09 Estetra SRL Compounds and their uses for alleviating menopause-associated symptoms
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
DE19975054I2 (de) 1987-08-08 2000-04-13 Akzo Nobel Nv Kontrazeptives Implantat
US4900734A (en) * 1987-08-27 1990-02-13 Maxson Wayne S Novel pharmaceutical composition containing estradiol and progesterone for oral administration
US5256421A (en) 1987-09-24 1993-10-26 Jencap Research Ltd. Hormone preparation and method
US5276022A (en) 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
FI101601B (fi) * 1987-09-24 1998-07-31 Jencap Res Ltd Ehkäisyvalmiste sekä estrogeenin ja progestiinin käyttö ehkäisyvalmist een valmistusmenetelmässä
US5108995A (en) 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US5422119A (en) 1987-09-24 1995-06-06 Jencap Research Ltd. Transdermal hormone replacement therapy
US5382873A (en) 1991-12-04 1995-01-17 U.S. Philips Corporation High-pressure discharge lamp with incandescing metal droplets
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
DE19513662A1 (de) * 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
PL181582B1 (pl) * 1995-06-07 2001-08-31 Ortho Mcneil Pharm Inc Plaster na skóre do zapobiegania owulacji u kobiety oraz plaster na skóre do przeprowadzania hormonalnej terapii substytucyjnej PL PL PL PL PL PL PL PL
US6506390B2 (en) * 1996-06-25 2003-01-14 Akzo Nobel Progestogen-anti-progestogen regimens
CA2267743C (en) * 1999-03-30 2011-07-26 Robert F. Casper Low dose estrogen interrupted hormone replacement therapy
US6653298B2 (en) * 2000-01-14 2003-11-25 Sterix Limited Composition
DE10100911A1 (de) * 2001-01-11 2002-08-01 Schering Ag Verfahren zur Hormonersatztherapie und dessen Darreichungsform

Similar Documents

Publication Publication Date Title
RU2005108977A (ru) Схема восполнения эстрогена
CA2267743A1 (en) Low dose estrogen interrupted hormone replacement therapy
JP2848919B2 (ja) 前更年期のホルモン異常の治療用、更年期のホルモン補充療法用、アンドロゲン誘引性障害の治療用および避妊用医薬
RU2001129160A (ru) Прерывистая гормонозаместительная терапия низкими дозами эстрогена
KR960001371B1 (ko) 폐경기 전의 여성용 혼합 제형 및 이를 포함하는 팩
JPH04290830A (ja) 避妊薬処方物
RU2189819C2 (ru) Схемы приема прогестогена-антипрогестогена
JP2010508275A5 (cg-RX-API-DMAC7.html)
PT99782B (pt) Processo de fabrico de contraceptivos orais de baixo teor em estrogenio
RU2004113305A (ru) Комбинированный эстрогенный/гестагенный препарат и его применение
JP2010248270A (ja) 避妊用の組成
AU2016264137B2 (en) Contraceptive compositions and methods for improved efficacy and modulation of side effects
RU96115196A (ru) Состав для контрацепции
JP2004508398A5 (cg-RX-API-DMAC7.html)
RU2001117204A (ru) Трехфазный пероральный контрацептив
RU2009120528A (ru) Способы гормональной терапии возрастающими дозами в режиме пролонгированного цикла
AR049112A1 (es) Composiciones, metodos y kit, para el tratamiento de trastorno disforico premenstrual
JP2008540482A5 (cg-RX-API-DMAC7.html)
WO2002094281A1 (en) Means and method for hormonal contraception
US7569560B2 (en) Extended cycle multiphasic oral contraceptive method
TW200534860A (en) Multiphase product for contraception based on a natural oestrogen
JPS62205024A (ja) エストロゲン欠乏症治療用組成物
JP2003535127A (ja) 低用量経口避妊薬用のスターターキット
CA2248841C (en) Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy
EP1462107A1 (en) Method of female contraception and kit for use in such method